Madrigal Pharmaceuticals Inc (MDGL) — Financial Flexibility Index
Madrigal Pharmaceuticals Inc (MDGL) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of $-133.07 Million (operating CF $-133.46 Million minus capex $390.00K) represents 0% of total liabilities ($656.90 Million). Check MDGL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Madrigal Pharmaceuticals Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Madrigal Pharmaceuticals Inc across 23 annual periods. For the full cash flow conversion analysis, see MDGL cash flow conversion.
Annual Financial Flexibility Index for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Madrigal Pharmaceuticals Inc. Explore MDGL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.29x | $-189.09 Million | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-454.11 Million | $-455.57 Million | $287.86 Million | ▼ -15.0% |
| 2023 | -1.37x | $-322.75 Million | $-324.23 Million | $235.21 Million | ▼ -0.9% |
| 2022 | -1.36x | $-224.64 Million | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.71 Million | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.34x | $-157.23 Million | $-157.56 Million | $47.02 Million | ▼ -105.6% |
| 2019 | -1.63x | $-41.45 Million | $-41.62 Million | $25.49 Million | ▲ +46.1% |
| 2018 | -3.02x | $-25.48 Million | $-25.51 Million | $8.44 Million | ▼ -36.7% |
| 2017 | -2.21x | $-22.19 Million | $-22.32 Million | $10.05 Million | ▲ +39.8% |
| 2016 | -3.67x | $-17.60 Million | $-17.61 Million | $4.80 Million | ▲ +8.6% |
| 2015 | -4.01x | $-71.39 Million | $-71.44 Million | $17.79 Million | ▼ -81.0% |
| 2014 | -2.22x | $-78.78 Million | $-78.92 Million | $35.54 Million | ▼ -33.4% |
| 2013 | -1.66x | $-76.64 Million | $-77.41 Million | $46.11 Million | ▲ +13.4% |
| 2012 | -1.92x | $-53.63 Million | $-54.13 Million | $27.95 Million | ▼ -13.4% |
| 2011 | -1.69x | $-46.61 Million | $-47.30 Million | $27.55 Million | ▼ -36.0% |
| 2010 | -1.24x | $-38.06 Million | $-38.20 Million | $30.59 Million | ▼ -13.3% |
| 2009 | -1.10x | $-26.36 Million | $-26.81 Million | $24.00 Million | ▼ -379.3% |
| 2008 | -0.23x | $-35.76 Million | $-37.94 Million | $156.04 Million | ▼ -175.7% |
| 2007 | 0.30x | $29.57 Million | $27.22 Million | $97.75 Million | ▲ +133.3% |
| 2006 | -0.91x | $-51.41 Million | $-52.98 Million | $56.54 Million | ▲ +70.1% |
| 2005 | -3.04x | $-57.00 Million | $-61.88 Million | $18.73 Million | ▼ -32.9% |
| 2004 | -2.29x | $-32.20 Million | $-33.80 Million | $14.06 Million | ▲ +65.0% |
| 2003 | -6.53x | $-22.84 Million | $-23.61 Million | $3.50 Million | — |